Kyn Therapeutics Banks $49M to Advance Cancer Immunometabolism Therapies – biolegacy

Kyn Therapeutics Banks $49M to Advance Cancer Immunometabolism Therapies

Post author:Sam
Post published:December 13, 2017
Post category:BioPharma

Investors were Atlas Venture and OrbiMed.
Source: BioSpace